Managers

Angels remain active but deal size falls

Paradigm Diagnostics attracts funding

Phoenix-based Paradigm Diagnostics, a precision medicine company focused on cancer diagnostics, has secured an undisclosed amount of funding. The investor was OSF Ventures.

Paradigm Diagnostics attracts funding

Phoenix-based Paradigm Diagnostics, a precision medicine company focused on cancer diagnostics, has secured an undisclosed amount of funding. The investor was OSF Ventures.

Noro-Moseley Partners closes a $180 mln eighth fund

Noro-Moseley Partners closes a $180 mln eighth fund

Hustle Fund is seeking $50 mln for sophomore fund

Hustle Fund is seeking $50 mln for sophomore fund

Quell Therapeutics pulls in funding

UK-based Quell Therapeutics, a new cell therapy company, has secured 35 million pounds in funding. Syncona was the lead investor with participation from UCL Technology Fund.

Quell Therapeutics pulls in funding

UK-based Quell Therapeutics, a new cell therapy company, has secured 35 million pounds in funding. Syncona was the lead investor with participation from UCL Technology Fund.

Jackson Square targets $150 mln for third fund

Jackson Square Ventures is seeking to raise $150 million for its third fund, according to an SEC filing. Based in San Francisco, the venture firm invests in SaaS and marketplace companies.